神经生长因子
医学
神经营养因子
再生(生物学)
神经营养素
发病机制
眼科
生长因子
脑源性神经营养因子
角膜
胶质细胞源性神经生长因子
角膜上皮
重组DNA
角膜溃疡
角膜溃疡
药理学
作者
Pedram Hamrah,Leyla Yavuz Saricay,Mehmet Cüneyt Özmen
出处
期刊:Cornea
[Lippincott Williams & Wilkins]
日期:2022-02-02
卷期号:41 (6): 673-679
被引量:15
标识
DOI:10.1097/ico.0000000000002974
摘要
ABSTRACT: Ophthalmologists find management of neurotrophic keratopathy (NK) challenging because conventional therapy lacks efficacy and may result in permanent loss of vision. Recombinant nerve growth factor (cenegermin) targets the underlying pathogenesis of NK by regenerating corneal nerves and healing the corneal epithelium through promotion of proliferation, maturing corneal epithelial cells. It has been approved as Food Drug Association-approved treatment of NK. In this article, the background, clinical trials, and impact of recombinant nerve growth factor as the first neurotrophic factor for the restoration of corneal integrity, homeostasis, and corneal nerve regeneration are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI